Top

Reactions Weekly

Published in:

01-04-2023 | Doxycycline | Case report

Cyclophosphamide/epirubicin/prednisolone

Cutaneous Mycobacterium marinum infection: 3 case reports

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Identifying patient details (age and sex) have been obtained through direct communication with the author. Additional information regarding indications, laboratory test findings, treatment details and outcomes as per Table 1 was updated.

Strobel K, et al. Diagnosis and therapy of Mycobacterium marinum: a single-center 21-year retrospective analysis. Journal der Deutschen Dermatologischen Gesellschaft 20 : 1211-1218, No. 9, Sep 2022. Available from: URL: http://doi.org/10.1111/ddg.14847

Title: Cyclophosphamide/epirubicin/prednisolone
Cutaneous Mycobacterium marinum infection: 3 case reports
Publication date: 01-04-2023
Publisher: Springer International Publishing
Keywords: Doxycycline
Polyneuropathy
Clarithromycin
Pulmonary Emphysema
Prednisolone
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-37592-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Cyclophosphamide/epirubicin/prednisolone

Cutaneous Mycobacterium marinum infection: 3 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Multiple drugs

Molnupiravir/nirmatrelvir/ritonavir

Brimonidine/timolol

Nintedanib

Ribavirin

Rituximab/vincristine